130 related articles for article (PubMed ID: 24469652)
1. Prostatic fluid free insulin-like growth factor-1 in relation to benign prostatic hyperplasia: a controlled study.
Ceylan C; Serel A; Doluoglu OG; Armağan A; Yüksel S
Urol J; 2014 Jan; 10(4):1067-71. PubMed ID: 24469652
[TBL] [Abstract][Full Text] [Related]
2. Elevated insulin and reduced insulin like growth factor binding protein-3/prostate specific antigen ratio with increase in prostate size in Benign Prostatic Hyperplasia.
Sreenivasulu K; Nandeesha H; Dorairajan LN; Rajappa M; Vinayagam V
Clin Chim Acta; 2017 Jun; 469():37-41. PubMed ID: 28300542
[TBL] [Abstract][Full Text] [Related]
3. Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.
Monti S; Di Silverio F; Iraci R; Martini C; Lanzara S; Falasca P; Poggi M; Stigliano A; Sciarra F; Toscano V
J Clin Endocrinol Metab; 2001 Apr; 86(4):1700-6. PubMed ID: 11297606
[TBL] [Abstract][Full Text] [Related]
4. The relationship between lower urinary tract symptoms/benign prostatic hyperplasia and the number of components of metabolic syndrome.
Park YW; Kim SB; Kwon H; Kang HC; Cho K; Lee KI; Kim YJ; Lee JH
Urology; 2013 Sep; 82(3):674-9. PubMed ID: 23850334
[TBL] [Abstract][Full Text] [Related]
5. 980-Nm Diode Laser Vaporization versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: Randomized Controlled Study.
Cetinkaya M; Onem K; Rifaioglu MM; Yalcin V
Urol J; 2015 Nov; 12(5):2355-61. PubMed ID: 26571321
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factors and risk of benign prostatic hyperplasia.
Chokkalingam AP; Gao YT; Deng J; Stanczyk FZ; Sesterhenn IA; Mostofi FK; Fraumeni JF; Hsing AW
Prostate; 2002 Jul; 52(2):98-105. PubMed ID: 12111701
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in benign prostatic hyperplasia and prostate cancer.
Khosravi J; Diamandi A; Mistry J; Scorilas A
J Clin Endocrinol Metab; 2001 Feb; 86(2):694-9. PubMed ID: 11158033
[TBL] [Abstract][Full Text] [Related]
8. BiVap saline vaporization of the prostate in men with benign prostatic hyperplasia: our clinical experience.
Karakose A; Aydogdu O; Atesci YZ
Urology; 2014 Mar; 83(3):570-5. PubMed ID: 24275275
[TBL] [Abstract][Full Text] [Related]
9. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
[TBL] [Abstract][Full Text] [Related]
10. Age-stratified normal values for prostate volume, PSA, maximum urinary flow rate, IPSS, and other LUTS/BPH indicators in the German male community-dwelling population aged 50 years or older.
Berges R; Oelke M
World J Urol; 2011 Apr; 29(2):171-8. PubMed ID: 21221974
[TBL] [Abstract][Full Text] [Related]
11. 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial--the GOLIATH study.
Bachmann A; Tubaro A; Barber N; d'Ancona F; Muir G; Witzsch U; Grimm MO; Benejam J; Stolzenburg JU; Riddick A; Pahernik S; Roelink H; Ameye F; Saussine C; Bruyère F; Loidl W; Larner T; Gogoi NK; Hindley R; Muschter R; Thorpe A; Shrotri N; Graham S; Hamann M; Miller K; Schostak M; Capitán C; Knispel H; Thomas JA
Eur Urol; 2014 May; 65(5):931-42. PubMed ID: 24331152
[TBL] [Abstract][Full Text] [Related]
12. Serum human glandular kallikrein (hK2) and insulin-like growth factor 1 (IGF-1) improve the discrimination between prostate cancer and benign prostatic hyperplasia in combination with total and %free PSA.
Scorilas A; Plebani M; Mazza S; Basso D; Soosaipillai AR; Katsaros N; Pagano F; Diamandis EP
Prostate; 2003 Feb; 54(3):220-9. PubMed ID: 12518327
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound image features of intravesical prostatic protrusion indicated failure of medication therapy of finasteride and doxazosin in patients with benign prostatic hyperplasia (LUTS/BPH).
Liu Q; Zhu Y; Liu J; Qi J; Kang J
Int Urol Nephrol; 2017 Mar; 49(3):399-404. PubMed ID: 27987130
[TBL] [Abstract][Full Text] [Related]
14. Three year results of the prostatic urethral L.I.F.T. study.
Roehrborn CG; Rukstalis DB; Barkin J; Gange SN; Shore ND; Giddens JL; Bolton DM; Cowan BE; Cantwell AL; McVary KT; Te AE; Gholami SS; Moseley WG; Chin PT; Dowling WT; Freedman SJ; Incze PF; Coffield KS; Borges FD; Rashid P
Can J Urol; 2015 Jun; 22(3):7772-82. PubMed ID: 26068624
[TBL] [Abstract][Full Text] [Related]
15. Benign Prostatic Hyperplasia Treatment with New Physiotherapeutic Device.
Allen S; Aghajanyan IG
Urol J; 2015 Nov; 12(5):2371-6. PubMed ID: 26571324
[TBL] [Abstract][Full Text] [Related]
16. Association between benign prostatic hyperplasia, body mass index, and metabolic syndrome in Chinese men.
Yin Z; Yang JR; Rao JM; Song W; Zhou KQ
Asian J Androl; 2015; 17(5):826-30. PubMed ID: 25677137
[TBL] [Abstract][Full Text] [Related]
17. Body Mass Index and Risk of Prostate Volume, International Prostate Symptom Score, Maximum Urinary Flow Rate, and Post-Void Residual in Benign Prostatic Hyperplasia Patients.
Li BH; Deng T; Huang Q; Zi H; Weng H; Zeng XT
Am J Mens Health; 2019; 13(4):1557988319870382. PubMed ID: 31426706
[TBL] [Abstract][Full Text] [Related]
18. Serum insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in localized, metastasized prostate cancer and benign prostatic hyperplasia.
Aksoy Y; Aksoy H; Bakan E; Atmaca AF; Akçay F
Urol Int; 2004; 72(1):62-5. PubMed ID: 14730168
[TBL] [Abstract][Full Text] [Related]
19. Gene expression of insulin receptor, insulin-like growth factor increases and insulin-like growth factor-binding protein-3 reduces with increase in prostate size in benign prostatic hyperplasia.
Sreenivasulu K; Nandeesha H; Dorairajan LN; Rajappa M; Vinayagam V; Cherupanakkal C
Aging Male; 2018 Jun; 21(2):138-144. PubMed ID: 29129118
[TBL] [Abstract][Full Text] [Related]
20. [Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia].
Bantis A; Zissimopoulos A; Kalaytzis C; Giannakopoulos S; Sountoulides P; Agelonidou E; Voudalikakis C; Touloupidis S
Hell J Nucl Med; 2007; 10(2):138-43. PubMed ID: 17684595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
